SIRT1 and metabolic dysfunction-associated steatotic liver disease: FXR also stimulates the expression of silent information regulator sirtuin 1 (SIRT1), which inhibits fatty acid synthesis and promotes oxidation; loss of SIRT1 results in MASLD.